The prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in intensive care unit (ICU) healthcare personnel (HCP) and its implications—a single-center, prospective, pilot study
Mohsin Sheraz Mughal, Ikwinder Preet Kaur, Chandler Patton, Nagy H. Mikhail, Chairut Vareechon, Kenneth Granet
Abstract
The prevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG antibodies in intensive care unit (ICU) healthcare personnel (HCP) and its implications—a single-center, prospective, pilot study - Volume 42 Issue 5
Topics & Concepts
MedicineIntensive care unitCoronavirusIntensive careSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Prospective cohort studyHealth careSingle CenterAntibodyIntensive care medicineEmergency medicineCoronavirus disease 2019 (COVID-19)VirologyInternal medicineImmunologyDiseaseInfectious disease (medical specialty)EconomicsEconomic growthInfection Control and VentilationCOVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 Research